MYGN
Myriad Genetics, Inc. · Healthcare · Medical - Diagnostics & Research
Momentum-inputs (vergelijkbare managers):
breedte van houders +30.0% ·
aandelenstroom -16.8% ·
netto nieuwe posities +20.0%
— formule
Versnippering van eigendom — meer houders, kleinere totale positie
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 84 | -5 | 70.39M | $401.85M | +6 | −11 |
| Q1 2026 | 92 | -3 | 73.19M | $329.45M | +3 | −6 |
| Q4 2025 | 95 | 0 | 80.50M | $495.06M | — | — |
| Q3 2025 | 19 | 0 | 56.51M | $408.57M | — | — |
| Q2 2025 | 16 | 0 | 51.45M | $273.22M | +1 | −1 |
| Q1 2025 | 13 | 0 | 25.12M | $222.86M | +1 | −1 |
| Q4 2024 | 13 | -1 | 27.01M | $370.33M | — | −1 |
| Q3 2024 | 13 | +3 | 18.94M | $518.67M | +3 | — |
| Q2 2024 | 10 | — | 22.76M | $556.69M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 6.72M | -18.7% | $183.97M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 6.72M | -18.7% | $183.97M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 6.72M | -18.7% | $183.97M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 6.72M | -18.7% | $183.97M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 6.72M | -18.7% | $183.97M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Millennium Management ✦ | 5.18M | +17.7% | $141.78M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passief) | 2.15M | +1.0% | $59.01M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passief) | 2.15M | +1.0% | $59.01M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Glenview Capital ✦ | 1.26M | -66.3% | $34.55M | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 1.15M | +2.2% | $31.54M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 1.15M | +2.2% | $31.54M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Point72 Asset Management ✦ | 1.06M | +26.7% | $29.14M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 13 | Fisher Asset Management ✦ | 602.84K | +47.9% | $16.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 365.37K | Nieuw | $10.01M | 0.0% | New | 1 | SEC ↗ |
| 15 | Arrowstreet Capital ✦ | 177.58K | Nieuw | $4.86M | 0.0% | New | 1 | SEC ↗ |
| 16 | Marshall Wace ✦ | 114.31K | Nieuw | $3.13M | 0.0% | New | 1 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 68.06K | -96.1% | $1.86M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 68.06K | -96.1% | $1.86M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 54.34K | -4.7% | $1.49M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 29.71K | +42.1% | $813,729 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 29.71K | +42.1% | $813,729 | 0.0% | ▲ Add | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Renaissance Technologies | $10.01M | 0.0% |
| Arrowstreet Capital | $4.86M | 0.0% |
| Marshall Wace | $3.13M | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 200 houders, 87.60M aandelen, $371.14M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.